Letters to the Editor  by MIRAVITLLES, M.
LETTERSTOTHEEDITOR 205doi:10.1053/rmed.2001.1246
Sir,
1-Anti-trypsin de¢ciency: epidemiology
and incidence
The epidemiology of a1-anti-trypsin de¢ciency, andparti-
cularly of its de¢cient variants, hasmerited increasing at-
tention fromresearchers. Since the initial investigation of
Fagerhol andTenfjord (1),manyreportshave contributed
to the understanding of the origins of the point muta-
tions responsible for di¡erent degrees of de¢ciency.
Furthermore, study of the prevalence of the di¡erent
mutations in a givenpopulationprovides thebasis for cal-
culating the number of individuals carrying the severe
homozygous PiZ form of the de¢ciency. Through these
studies, it has been possible to establish the high degree
of under-diagnosis of the de¢ciency in most countries.
One of themain contributions to the analysis of the pre-
valence of the di¡erent de¢cient mutations was re-
ported by Hutchison (2,3) who, in a comprehensive
review, suggested the geographical distribution of the Pi
types S and Z in Europe.These data have been the basis
of other reports addressing the distribution of these
phenotypes in di¡erent populations. In a recent review
(4), some of these data were presented andmodi¢ed ac-
cording to new data obtained in populations of the Iber-
ian peninsula (5^7). Basically, these new data indicated
that the population of Basque origin does present the Z
variant, in contrast towhatwas postulatedpreviously.To
illustrate these results, the original ¢gures by Hutchisonwere modi¢ed accordingly. Unfortunately, owing to an
error attributable to the author alone, the original
source of information was not mentioned in this review.
With this letter, the author wishes to acknowledge the
original work by Hutchison (2,3) and apologises for the
omission.
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